Oral MS drug, FTY720, works, but has side effects - FDA
Oral MS drug, FTY720, works, but has side effects - FDA
Federal health regulators said Tuesday a highly anticipated Novartis drug for multiple sclerosis appears effective but carries a number of side effects, including lung and eye problems.
Swiss drugmaker Novartis has asked the Food and Drug Administration to approve its drug Gilenia to treat patients with relapsed multiple sclerosis, which causes tremors and movement problems. The drug is a daily pill and would offer an alternative to older injectable drugs.
FDA reviewers said two studies of the drug “provide substantial evidence for an effect.”... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309
MS-UK - http://www.ms-uk.org/
From the attached article -- The FDA's panel of nervous system experts voted 25-0 today (June 10) that Gilenia (Fingolimod) helps reduce relapses. The panel is scheduled to vote on the drug's safety later this afternoon. The FDA is not required to follow the group's advice, though it usually does.
http://finance.yahoo.com/news/FDA-panel ... 4.html?x=0
http://finance.yahoo.com/news/FDA-panel ... 4.html?x=0
Here's the link to Novartis' press release issued this evening on today's FDA events.
http://hugin.info/134323/R/1423236/372134.pdf
http://hugin.info/134323/R/1423236/372134.pdf
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1631 Views
-
Last post by NHE
-
- 0 Replies
- 3127 Views
-
Last post by NHE
-
- 0 Replies
- 4272 Views
-
Last post by NHE
-
- 0 Replies
- 1950 Views
-
Last post by NHE
-
- 0 Replies
- 725 Views
-
Last post by frodo
-
- 0 Replies
- 1842 Views
-
Last post by frodo
-
- 1 Replies
- 1017 Views
-
Last post by Petr75
-
- 0 Replies
- 3862 Views
-
Last post by NHE
-
- 0 Replies
- 704 Views
-
Last post by NHE